Cargando…

Clinical antidiabetic medication used in Alzheimer’s disease: From basic discovery to therapeutics development

Alzheimer’s disease (AD) is a common neurodegenerative disease. Type 2 diabetes mellitus (T2DM) appears to increase and contributing to the risk of AD. Therefore, there is increasing concern about clinical antidiabetic medication used in AD. Most of them show some potential in basic research, but no...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Juan, Huang, Nanqu, Cui, Di, Shi, Jingshan, Qiu, Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950577/ https://www.ncbi.nlm.nih.gov/pubmed/36845652 http://dx.doi.org/10.3389/fnagi.2023.1122300

Ejemplares similares

Natural bioactive compounds in Alzheimer's disease: From the perspective of type 3 diabetes mellitus
por: Huang, Juan, et al.
Publicado: (2023)

Isocitrate Dehydrogenase Mutations in Glioma: From Basic Discovery to Therapeutics Development
por: Huang, Juan, et al.
Publicado: (2019)

Dendrobium alkaloids decrease Aβ by regulating α- and β-secretases in hippocampal neurons of SD rats
por: Huang, Juan, et al.
Publicado: (2019)

TDP-43: From Alzheimer’s Disease to Limbic-Predominant Age-Related TDP-43 Encephalopathy
por: Huang, Wendi, et al.
Publicado: (2020)

Application of Artificial Intelligence in Discovery and Development of Anticancer and Antidiabetic Therapeutic Agents
por: Alqahtani, Amal
Publicado: (2022)

Resveratrol against 6-OHDA-induced damage of PC12 cells via PI3K/Akt
por: Huang, Nanqu, et al.
Publicado: (2021)

Retracted: Application of Artificial Intelligence in Discovery and Development of Anticancer and Antidiabetic Therapeutic Agents
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

The role of TREM2 in Alzheimer’s disease: from the perspective of Tau
por: Huang, Wendi, et al.
Publicado: (2023)

Icariin protects against sodium azide—induced neurotoxicity by activating the PI3K/Akt/GSK-3β signaling pathway
por: Zhang, Ying, et al.
Publicado: (2020)

A Novel Multifunctional 5,6-Dimethoxy-Indanone-Chalcone-Carbamate Hybrids Alleviates Cognitive Decline in Alzheimer’s Disease by Dual Inhibition of Acetylcholinesterase and Inflammation
por: Liu, Chan, et al.
Publicado: (2022)

Editorial: Noise-induced hearing loss: From basic to clinical research
por: Huang, Zhiwu, et al.
Publicado: (2023)

New therapeutic strategy for Alzheimer's disease using antidiabetes agents
por: Yokono, Koichi
Publicado: (2013)

Research Progress of Pyroptosis in Alzheimer’s Disease
por: Xue, Weiyue, et al.
Publicado: (2022)

Fluid Biomarkers in Clinical Trials of Alzheimer’s Disease Therapeutics
por: Ritter, Aaron, et al.
Publicado: (2015)

Antidiabetic therapies and Alzheimer disease
por: Bendlin, Barbara B
Publicado: (2019)

Endoscope ear pick: An emerging but neglected medical device
por: Huang, Wendi, et al.
Publicado: (2022)

Pyroptosis as a candidate therapeutic target for Alzheimer’s disease
por: Huang, Yuehua, et al.
Publicado: (2022)

Frontiers in therapeutic development of allopregnanolone for Alzheimer’s disease and other neurological disorders
por: Irwin, Ronald W., et al.
Publicado: (2014)

Microglia in Alzheimer’s disease: pathogenesis, mechanisms, and therapeutic potentials
por: Miao, Jifei, et al.
Publicado: (2023)

Antidiabetic Drugs in the Treatment of Alzheimer’s Disease
por: Michailidis, Michalis, et al.
Publicado: (2022)

Current and future therapeutic strategies for Alzheimer’s disease: an overview of drug development bottlenecks
por: Peng, Yong, et al.
Publicado: (2023)

China’s drug clinical trial institution record-keeping system: Qualification requirements for PI are the key
por: Huang, Nanqu, et al.
Publicado: (2023)

Discovery of Novel Drug Candidates for Alzheimer’s Disease by Molecular Network Modeling
por: Zhou, Jiaxin, et al.
Publicado: (2022)

Epigenetic Modifications in Alzheimer’s Neuropathology and Therapeutics
por: Esposito, Michelle, et al.
Publicado: (2019)

Ferroptosis: From Basic Research to Clinical Therapeutics in Hepatocellular Carcinoma
por: Huang, Ziyue, et al.
Publicado: (2023)

TWEAK/Fn14 Axis-Targeted Therapeutics: Moving Basic Science Discoveries to the Clinic
por: Cheng, Emily, et al.
Publicado: (2013)

Discovery and validation of Ferroptosis-related molecular patterns and immune characteristics in Alzheimer’s disease
por: He, Yi-Jie, et al.
Publicado: (2022)

Vestibular prosthesis: from basic research to clinics
por: Soto, Enrique, et al.
Publicado: (2023)

Antidiabetic Phytochemicals From Medicinal Plants: Prospective Candidates for New Drug Discovery and Development
por: Alam, Safaet, et al.
Publicado: (2022)

Exploring the Potential of Antidiabetic Agents as Therapeutic Approaches for Alzheimer's and Parkinson's Diseases: A Comprehensive Review
por: Koshatwar, Mahima, et al.
Publicado: (2023)

Nanoliposomes as a Therapeutic Tool for Alzheimer’s Disease
por: Ordóñez-Gutiérrez, Lara, et al.
Publicado: (2020)

A Strategy for Discovery and Verification of Candidate Biomarkers in Cerebrospinal Fluid of Preclinical Alzheimer’s Disease
por: Zhong, Xiaofang, et al.
Publicado: (2019)

Targeting specific HATs for neurodegenerative disease treatment: translating basic biology to therapeutic possibilities
por: Pirooznia, Sheila K., et al.
Publicado: (2013)

Inflammation and Insulin Resistance as Risk Factors and Potential Therapeutic Targets for Alzheimer’s Disease
por: Vinuesa, Angeles, et al.
Publicado: (2021)

Editorial: New Advances in Electrocochleography for Clinical and Basic Investigation
por: Pienkowski, Martin, et al.
Publicado: (2018)

Orofacial Neuropathic Pain-Basic Research and Their Clinical Relevancies
por: Shinoda, Masamichi, et al.
Publicado: (2021)

Genome-Wide Association Study of Alzheimer’s Disease Brain Imaging Biomarkers and Neuropsychological Phenotypes in the European Medical Information Framework for Alzheimer’s Disease Multimodal Biomarker Discovery Dataset
por: Homann, Jan, et al.
Publicado: (2022)

P2X(7) Receptors in Neurodegeneration: Potential Therapeutic Applications From Basic to Clinical Approaches
por: Territo, Paul R., et al.
Publicado: (2021)

NSAIDs: How they Work and their Prospects as Therapeutics in Alzheimer's Disease
por: Sastre, Magdalena, et al.
Publicado: (2010)

The Contribution and Therapeutic Potential of Epigenetic Modifications in Alzheimer’s Disease
por: Wood, Ian C.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_df0tlpohc7pmv7st3anrolvbpr